Ichiro Fuse

1.2k total citations
75 papers, 924 citations indexed

About

Ichiro Fuse is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Ichiro Fuse has authored 75 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 17 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Ichiro Fuse's work include Platelet Disorders and Treatments (14 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (8 papers). Ichiro Fuse is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (8 papers). Ichiro Fuse collaborates with scholars based in Japan, United States and Australia. Ichiro Fuse's co-authors include Yoshifusa Aizawa, Hsin‐Hsiung Tai, Ken Toba, H.-H. Tai, Tatsuo Furukawa, Miwako Narita, Masuhiro Takahashi, Akira Hattori, Akira Shibata and Y. Uesugi and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Ichiro Fuse

72 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ichiro Fuse Japan 19 274 265 251 143 103 75 924
R Coda Italy 15 335 1.2× 288 1.1× 316 1.3× 132 0.9× 138 1.3× 44 1.2k
Simon Allen United Kingdom 19 307 1.1× 175 0.7× 168 0.7× 102 0.7× 81 0.8× 63 1.1k
Zhenyin Tao United States 12 202 0.7× 301 1.1× 423 1.7× 138 1.0× 61 0.6× 16 960
Daniel H. Sturn Austria 16 290 1.1× 217 0.8× 192 0.8× 57 0.4× 108 1.0× 20 785
Helen A. Bull United Kingdom 18 192 0.7× 133 0.5× 202 0.8× 68 0.5× 48 0.5× 45 899
Naadiya Carrim Canada 8 170 0.6× 475 1.8× 182 0.7× 77 0.5× 121 1.2× 9 901
Laurent Burnier Switzerland 17 475 1.7× 521 2.0× 394 1.6× 177 1.2× 68 0.7× 28 1.3k
Anne Zufferey Switzerland 16 317 1.2× 722 2.7× 271 1.1× 151 1.1× 103 1.0× 24 1.3k
Jin Zhou China 19 262 1.0× 180 0.7× 299 1.2× 107 0.7× 163 1.6× 53 1.0k
K. Vinod Vijayan United States 21 312 1.1× 472 1.8× 173 0.7× 69 0.5× 121 1.2× 43 1.2k

Countries citing papers authored by Ichiro Fuse

Since Specialization
Citations

This map shows the geographic impact of Ichiro Fuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Fuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Fuse more than expected).

Fields of papers citing papers by Ichiro Fuse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Fuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Fuse. The network helps show where Ichiro Fuse may publish in the future.

Co-authorship network of co-authors of Ichiro Fuse

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Fuse. A scholar is included among the top collaborators of Ichiro Fuse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Fuse. Ichiro Fuse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furukawa, Kazuo, Ichiro Fuse, Yuriko Iwakura, et al.. (2017). Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation. Cardiovascular Diabetology. 16(1). 20–20. 9 indexed citations
3.
Narita, Miwako, Masayoshi Masuko, Norihiro Watanabe, et al.. (2010). WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE. International Journal of Medical Sciences. 7(2). 72–81. 24 indexed citations
4.
Oda, Masato, Ken Toba, Takuya Ozawa, et al.. (2010). Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia. Journal of Molecular and Cellular Cardiology. 49(3). 347–353. 8 indexed citations
5.
Narita, Miwako, Norihiro Watanabe, Nozomi Tochiki, et al.. (2010). WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval. Medical Oncology. 28(1). 219–230. 9 indexed citations
7.
Tsuchiyama, Junjiro, T. Yoshino, Takayuki Saito, et al.. (2008). Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions. Bone Marrow Transplantation. 43(11). 863–873. 13 indexed citations
8.
Tochiki, Nozomi, Miwako Narita, Zhi Zheng, et al.. (2008). Induction of recipient cell-specific donor T-cell anergy by UV-C-irradiated recipient immature monocyte-derived dendritic cells. Bone Marrow Transplantation. 41(12). 1037–1045. 2 indexed citations
9.
Takahashi, Hidenobu, et al.. (2003). Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagulation & Fibrinolysis. 14(1). 87–93. 23 indexed citations
10.
Yamada, Keiko, et al.. (2002). Anti Rh D+C antibody-mediated hemolytic disease of bizygotic twin newborns delivered from a Rh D and C-negative woman without a history of prior pregnancy or blood transfusion.. Journal of the Japan Society of Blood Transfusion. 48(3). 304–308. 1 indexed citations
12.
Tsuchiyama, Junjiro, Tadashi Yoshino, Ken Toba, et al.. (2002). Induction and characterization of cutaneous lymphocyte antigen on natural killer cells. British Journal of Haematology. 118(2). 654–662. 23 indexed citations
13.
Seki, Yoshinobu, Tadashi Koike, Masahiko Yano, et al.. (2002). Bone marrow necrosis with dyspnea in a patient with malignant lymphoma and plasma levels of thrombomodulin, tumor necrosis factor‐α, and D‐dimer. American Journal of Hematology. 70(3). 250–253. 9 indexed citations
14.
Fuse, Ichiro, Wataru Higuchi, & Y. Uesugi. (2001). Variant Type 2B von Willebrand Disease; No Responsible Mutations atthe von Willebrand Factor A1 Domain and the Surrounding Region. 49(1). 11–17. 1 indexed citations
16.
Hashimoto, Shigeo, Ken Toba, Ichiro Fuse, et al.. (2000). Thrombopoietin activates the growth of megakaryoblasts in patients withchronic myeloproliferative disorders and myelodysplastic syndrome. European Journal Of Haematology. 64(4). 225–230. 7 indexed citations
17.
Niwano, Hiroe, Shin Aoki, N Tsukada, et al.. (1997). An aggressive case of Burkitt's lymphoma with t(8;14) and c-myc rearrangement transformed from CD5+ B-cell lymphoma. Annals of Hematology. 75(5-6). 221–225. 5 indexed citations
18.
Fuse, Ichiro, et al.. (1993). Paroxysmal Nocturnal Hemoglobinuria with Myelofibrosis: Progression to Acute Myeloblastic Leukemia. Leukemia & lymphoma. 12(1-2). 137–142. 17 indexed citations
19.
Takahashi, Yoshitaka, Natsuo Ueda, Tanihiro Yoshimoto, et al.. (1992). Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochemical and Biophysical Research Communications. 182(2). 433–438. 34 indexed citations
20.
Fuse, Ichiro & Hsin‐Hsiung Tai. (1988). Does protein kinase C activation mediate thrombin-induced arachidonate release in human platelets?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 972(1). 54–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026